| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
National Research Corp (NRC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. NRC is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 172.0K | $3.18M | - | |
| COO | 140.5K | $2.60M | - | |
| VP | 100.0K | $1.85M | - | |
| Dir | 22.6K | $417.9K | - | |
| Dir | 22.6K | $417.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 21, 2018 | Berwick Donald M | Director | Sell | 25,309 | $34.54 | $874,231.30 | -64.4% | |
| May 18, 2018 | Nunnelly John N | Director | Sale+OE | 31,778 | $34.66 | $1,101,487.43 | -24.8% | |
| May 16, 2018 | Nunnelly John N | Director | Sale+OE | 5,952 | $34.67 | $206,384.41 | -12.6% | |
| May 15, 2018 | Nunnelly John N | Director | Sale+OE | 22,985 | $34.47 | $792,363.98 | -21.5% | |
| May 11, 2018 | Nunnelly John N | Director | Sale+OE | 18,514 | $33.90 | $627,537.52 | -18.1% | |
| May 9, 2018 | Nunnelly John N | Director | Sale+OE | 8,654 | $33.31 | $288,238.78 | -14.3% | |
| May 8, 2018 | Nunnelly John N | Director | Sale+OE | 8,594 | $34.13 | $293,299.52 | -5.1% | |
| May 3, 2018 | Nunnelly John N | Director | Sale+OE | 18,056 | $34.49 | $622,833.29 | -9.8% | |
| Apr 23, 2018 | Hays Michael D. | CEO | Sell | 80 | $35.00 | $2,800.00 | -100% | |
| Apr 2, 2018 | Nunnelly John N | Director | Sale+OE | 3,000 | $28.75 | $86,250.00 | -9.5% |